Metabolic syndrome and cancer risk: A bidirectional two-sample Mendelian randomization study
Experimental Gerontology · 2025
DOI: 10.1016/j.exger.2025.112802 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Gerontology, 2025. Verfasst von Qian Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Health Management Department, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. Hauptthemen laut MEDLINE: Metabolic Syndrome, Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Xi'an Jiaotong University, National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND: Emerging evidence suggests that metabolic syndrome (MetS) contributes to cancer development, but the causal relationship remains unclear. This study aimed to explore the potential causal associations between MetS and 50 types of cancer (including the main cancer subtypes) using bidirectional Mendelian randomization (MR) analysis. METHODS: Genome-wide association study (GWAS) data were downloaded from the IEU-GWAS database and CNCR-CTGLAB. We investigated the causal associations between MetS and cancer via the inverse variance-weighted (IVW) method. We used sensitivity analyses, including Cochran's Q, MR-PRESSO, and MR-Egger intercept tests, to verify the reliability of the MR results. The P-value of the IVW analysis was adjusted for the false discovery rate (FDR) to avoid false-positive results. RESULTS: The results of the IVW analysis revealed that genetically predicted MetS was positively associated with an increased risk of 11 types of cancers (P-FDR 0.05) in the MR Egger intercept and MR-PRESSO tests, confirming the robustness of the results. Moreover, there were no reverse causalities between these cancers and MetS. CONCLUSION: Our study revealed a positive causal relationship between genetically predicted MetS and lung cancer, lung squamous cell carcinoma, endometrial cancer, colorectal cancer, hepatic cancer, non-follicular lymphoma cancer, primary lymphoid and hematopoietic malignant neoplasm cancer, and thyroid cancer, and a negative causal relationship between genetically predicted MetS and prostate cancer, which provides important insights into the cancer prevention, treatment, and long-term health management of MetS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Health Management Department, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
- Department of Thyroid Surgery, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
- Department of Radiology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
- The Comprehensive Breast Center, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
- Department of Epidemiology and Biostatistics, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, China. Electronic address: zhuanggh@mail.xjtu.edu.cn.
Förderung
- Xi'an Jiaotong University
- National Natural Science Foundation of China
Zitieren
APA
Wang, Q., Li, J., Qiao, H., Zhang, Y., Xu, Y., Chen, R., Liu, K., Zhang, S., & Zhuang, G. (2025). Metabolic syndrome and cancer risk: A bidirectional two-sample Mendelian randomization study. Experimental Gerontology. https://doi.org/10.1016/j.exger.2025.112802
Vancouver
Wang Q, Li J, Qiao H, Zhang Y, Xu Y, Chen R, et al. Metabolic syndrome and cancer risk: A bidirectional two-sample Mendelian randomization study. Experimental Gerontology. 2025. doi:10.1016/j.exger.2025.112802
BibTeX
@article{Wang2025,
author = {Wang, Qian and Li, Jia and Qiao, Hao and Zhang, Yuelang and Xu, Ying and Chen, Rui and Liu, Kaishunzi and Zhang, Shuqun and Zhuang, Guihua},
title = {Metabolic syndrome and cancer risk: A bidirectional two-sample Mendelian randomization study},
journal = {Experimental Gerontology},
year = {2025},
doi = {10.1016/j.exger.2025.112802}
}
EUVIMED